ReviewPain reports
Potential for increased prevalence of neuropathic pain after the COVID-19 pandemic.
Review in Pain reports. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05638620 (Evaluating the Effectiveness of Dual Sympathetic Blocks for Patients Experiencing Sympathetically-Mediated Symptoms From Post-Acute Sequelae of SARS-CoV-2), which is not on this map. Cited by 56 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Evaluating the Effectiveness of Dual Sympathetic Blocks for Patients Experiencing Sympathetically-Mediated Symptoms From Post-Acute Sequelae of SARS-CoV-2 (PASC)
Who cites it
56 citing papers in PubMed, 2 syntheses or guidelines pooled it, 102 citations in OpenAlex.
- A systematic review and meta-analysis of neuropathic pain associated with coronavirus disease 2019.European journal of pain (London, England) · 2023Pooled it
- Neuropathic Pain Associated with COVID-19: a Systematic Review of Case Reports.Current pain and headache reports · 2022Pooled it
- SARS-CoV-2 Spike Peptides Trigger Nociceptive Responses Through Spinal TLR4 Pathways.European journal of pain (London, England) · 2026Article
- Long-Term Corneal Nerve and Ocular Surface Findings After COVID-19 Requiring Hospitalisation: An Observational Follow-Up Study.Clinical ophthalmology (Auckland, N.Z.) · 2026Article
- Cooled Radiofrequency Ablation of the Lateral Femoral Cutaneous Nerve for Chronic Refractory Meralgia Paresthetica.Current pain and headache reports · 2025Review
- Post-acute sequelae SARS-CoV-2 infection and neuropathic pain: a narrative review of the literature and future directions.Pain management · 2025Review
- Review
- Alcohol Consumption Modulates the Development of Chronic Pain in COVID-19 Patients: A Network Meta-Analysis.ACS pharmacology & translational science · 2025Article
- Prescription rates in different groups of outpatients with covid-19 and other acute respiratory infections: comparative observational study based on German routine data.BMJ medicine · 2025Article
- A clinical approach to the investigation and management of long COVID associated neuropathic pain.European archives of psychiatry and clinical neuroscience · 2024Review
- Peripheral Nerve Stimulation for Neuropathic Pain Management: A Narrative Review.Pain and therapy · 2024Review
- A narrative review of the complex panorama regarding chronic neuropathic pain mainly for the psychological issues.Heliyon · 2024Review
- Neuropathic component of chronic musculoskeletal pain in patients with post-COVID-19: A cross-sectional study.Archives of rheumatology · 2024Article
- Prevalence and Management of Chronic Pain, Including Neuropathic Pain, in Dialysis Patients with End-Stage Renal Disease.Medical science monitor : international medical journal of experimental and clinical research · 2024Article
- Research progress of post-acute sequelae after SARS-CoV-2 infection.Cell death & disease · 2024Review
- Sub-acute pain after childbirth during COVID-19 pandemic: A secondary analysis of A prospective clinical trial.Heliyon · 2024Article
- Pain types and risk factors in post-COVID-19.Turkish journal of physical medicine and rehabilitation · 2024Article
- Neuropathic Corneal Pain after Coronavirus Disease 2019 (COVID-19) Infection.Diseases (Basel, Switzerland) · 2024Article
- Pain Trajectories among U.S. Veterans During COVID-19.The journal of pain · 2023Article
- Pain associated with COVID-19 vaccination is unrelated to skin biopsy abnormalities.Pain reports · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Although coronavirus disease 2019 (COVID-19) most commonly manifests with acute respiratory symptoms, one very common symptom of COVID-19 is pain. As COVID-19 often causes peripheral or central neurological complications, it is anticipated that a number of the chronic pain complications of COVID-19 will be neuropathic. This review first examines the most common viral infections responsible for neurological complications including neuropathic pain. These encompass herpes zoster, HIV, poliovirus, enteroviruses, and several tropical viruses. Neurological complications of COVID-19 including in particular Guillain-Barré syndrome, myelitis, and stroke are reviewed with regards to their potential risk of chronic neuropathic pain. Prospective longitudinal cohorts of patients should be implemented to evaluate the exact risk of neuropathic pain after COVID-19.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.